Colorectal cancer often begins as silent, benign polyps within the colon. These growths, initially small and undetectable, ...

Tripura hospital doctors successfully removed a pre-cancerous polyp from a Bangladeshi patient. The patient is recovering ...

Shares of Recursion Pharmaceuticals are trading higher Monday after the company reported positive data from an ongoing trial.

Most people never see what colon cancer actually looks like. A gastroenterologist breaks it down, showing how tiny polyps silently grow into dangerous tumours.

REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden ...

Recursion Pharma, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped ​reduce abnormal growths in the colon in patients with a rare ...

Recursion Pharmaceuticals, Inc. is rated a Sell due to cash burn, Q3 net loss of $162.25M and operational trends. Learn more ...

A meta-analysis shows varying effectiveness of treatments in restoring smell in patients with chronic rhinosinusitis with ...

She was only 12 when she was diagnosed with familial adenomatous polyposis (FAP), an inherited condition that causes hundreds ...

Periods lasting longer than seven days are not normal, say gynaecologists. Experts explain the common causes of prolonged ...

New research finds that women who regularly eat high amounts of UPFs are at a significantly higher risk of developing an ...

Recursion Pharmaceuticals › Recursion Pharmaceuticals (NASDAQ: RXRX) was in the headlines on Monday, and for the right reason ...